Hbk Investments L P Galapagos Nv Transaction History

Hbk Investments L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $88,726 - $117,695	979 Added 34.96%	3,779 $425,000
Q2 2018 Aug 14, 2018	SELL	$88.4 - $105.34 $494,951 - $589,798	-5,599 Reduced 66.66%	2,800 $258,000
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $511,488 - $650,684	5,412 Added 181.19%	8,399 $838,000
Q4 2017 Feb 14, 2018	SELL	$84.48 - $104.02 $802,897 - $988,606	-9,504 Reduced 76.09%	2,987 $280,000
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $913,966 - $1.29 Million	12,491	12,491 $1.27 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.